A PK Similarity Study of Two Sintilimab Products Produced by Different Processes in Advanced or Metastatic NSCLC Patients
Clinical trial NCT04177290 · COMPLETED
Trial details
- NCT number
- NCT04177290
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-02
- Primary completion
- 2021-02-28
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.